YD Bio (YDES) Balance Sheet: Assets & Liabilities

YD Bio (YDES) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), YD Bio reported total assets of $13.78M and total liabilities of $16.64M. Shareholders' equity was negative at −$2.86M, meaning liabilities exceed assets. Total debt stood at $6.76K against $6.01M in cash and short-term investments, a net cash position of $6.00M.

YD Bio Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for YD Bio Limited (YDES) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	6.01	3.13	0.09	0.01	0.01	0.69
Cash & Short-Term Investments	6.01	3.13	0.09	0.01	0.01	0.69
Accounts Receivable	0.71	0.09	0.10	0.02	0.00	0.00
Inventory	1.88	0.04	0.07	0.00	0.00	0.00
Other Current Assets	1.07	0.04	0.02	0.17	0.12	0.14
Total Current Assets	9.67	3.47	0.27	0.20	0.13	0.83
Non-Current Assets
Property, Plant & Equipment (Net)	0.07	0.09	0.01	0.00	0.00	0.00
Long-Term Investments	0.00	10.53	0.01	17.73	117.93	116.73
Intangible Assets	2.61	2.68	0.00	0.00	0.00	0.00
Other Non-Current Assets	1.43	-9.90	0.02	0.00	0.00	0.02
Total Non-Current Assets	4.11	3.40	0.05	17.73	117.93	116.76
Total Assets	13.78	6.86	0.32	17.93	118.06	117.59
Current Liabilities
Accounts Payable	0.41	0.03	0.02	0.00	0.00	0.00
Short-Term Debt	0.01	0.00	0.03	0.00	0.00	0.00
Current Portion of Long-Term Debt	-	-	0.03	0.03	-	-
Accrued Liabilities	0.44	0.18	0.01	0.01	-	-
Deferred Revenue	0.03	0.00	0.00	0.00	0.00	0.00
Other Current Liabilities	1.19	0.22	0.22	5.55	2.00	0.30
Total Current Liabilities	1.64	0.26	0.30	5.55	2.00	0.30
Non-Current Liabilities
Long-Term Debt	0.00	0.01	0.00	0.00	0.00	0.00
Deferred Tax Liabilities	0.00	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	14.99	0.00	2.20	1.18	7.11	17.51
Total Non-Current Liabilities	14.99	0.01	2.20	1.18	7.11	17.51
Total Liabilities	16.64	0.27	0.30	6.74	9.11	17.81
Stockholders' Equity
Common Stock	0.01	0.01	0.11	17.73	115.00	115.00
Retained Earnings	-10.24	-1.93	-0.52	-6.53	-6.52	-15.22
Accumulated Other Comprehensive Income	0.21	0.05	0.05	0.00	0.00	0.00
Additional Paid-in Capital	7.16	8.47	0.39	0.00	0.48	0.00
Shares Outstanding	70.79	70.10	70.10	-	-	-
Total Stockholders' Equity	-2.86	6.59	0.02	11.20	108.96	99.78
Total Liabilities & Equity	13.78	6.86	0.32	17.93	118.06	117.59

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About YD Bio Balance Sheet

How much debt does YD Bio have?

YD Bio had total debt of $6.76K as of Dec 31, 2025, against $6.01M in cash and short-term investments. Total debt was $5.97K a year earlier.

What are YD Bio's total assets?

YD Bio reported total assets of $13.78M as of Dec 31, 2025, up 100.7% from $6.86M a year earlier. Total liabilities were $16.64M.

What is YD Bio's shareholders' equity?

YD Bio's shareholders' equity was negative at −$2.86M as of Dec 31, 2025, so its liabilities exceeded its assets.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition